Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Document Sample
Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile Powered By Docstoc
					                    Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare -
                                        Deals and Alliances Profile
       Reference Code: GDPH137612D                                                                                                           Publication Date: JAN 2013

      Company Overview                                                                                        Key Facts
      Selexys Pharmaceuticals Corporation (Selexys Pharmaceuticals) is a biotechnology
                                                                                                              Selexys Pharmaceuticals Corporation,
      company, based in the US. It develops drugs for the treatment of inflammatory and
                                                                                                              Pharmaceuticals & Healthcare, Key Facts
      thrombotic diseases. The company aims at binding two proteins, P-selectin and
      PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic                                Web Address                      www.selexys.com
      disorders. Selexys Pharmaceuticals’ product pipeline includes Anti-P-selectin, which
                                                                                                               Revenue (US$ million)                         NA
      blocks selectin function and prevents white blood cells from initiating inflammation
      and Anti-PSGL-1, a monoclonal antibodies targeted at inflammatory bowel diseases.                        Number of Employees                           NA
                                                                                                               GlobalData

      Financial Deals Landscape
        Selexys Pharmaceuticals Corporation, Pharmaceuticals &                            Selexys Pharmaceuticals Corporation, Pharmaceuticals &
        Healthcare, Deals by Type, 2007 to YTD 2013                                       Healthcare, Deals By Year, 2007 to YTD 2013


                                                                                                                                                       2
                                                                                                          2


                                                                                           No. of Deals                          1       1      1
                                                                                                          1


                                                                                                                 0      0                                     0
                                                                                                          0
                                                                                                               2007    2008   2009     2010    2011   2012   YTD
                                                                                                                                                             2013


                                                                                          Note: Deals include all announced pharmaceuticals & healthcare deals
         Note: Deals include all announced pharmaceuticals & healthcare deals from
                                                                                          from 2006 onwards, GlobalData
         2006 onwards, GlobalData


         Selexys Pharmaceuticals Corporation, Pharmaceuticals &                           Selexys Pharmaceuticals Corporation, Pharmaceuticals &
         Healthcare, Deals By Region, 2007 to YTD 2013                                    Healthcare, Deals By Therapy Area, 2007 to YTD 2013

                         6     5                                                                          6
                                                                                                                        5
          No. of Deals




                         5
                                                                                                          5
                         4                                                                                                               4             4
                                                                                           No. of Deals




                         3                                                                                4
                         2                                                                                3
                         1              0         0        0         0
                         0                                                                                2
                             North    Asia-     Europe   Middle   South                                   1
                             Americ   Pacific             East     and
                               a                          and     Central                                 0
                                                         Africa   Americ                                             Immunolog       Cardiovasc Hematologi
                                                                    a                                                    y              ular    cal D isord …


         Note: Deals include all announced pharmaceuticals & healthcare deals             Note: Deals include all announced pharmaceuticals & healthcare deals
         from 2006 onwards, GlobalData                                                    from 2006 onwards, GlobalData




Selexys Pharmaceuticals Corporation - Pharmaceuticals &                                                                                       Reference Code: GDPH137612D
Healthcare - Deals and Alliances Profile
Source : www.globalcompanyintelligence.com                                                                                                                                Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 3
          List of Figures ................................................................................................................................................................................. 3
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ...................................... 3
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare Deals By Type, 2007 to YTD 2013 ...................................... 5
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Region, 2007 to YTD 2013 .................................. 6
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2007 to YTD 2013 ........................ 7
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs
       Upfront Payment, 2007 to YTD 2013 ................................................................................................................................................. 8
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deals Summary, 2007 to YTD 2013 ................................... 9
       Selexys Pharmaceuticals Corporation, Pharmaceuticals & Healthcare, Deal Details ...................................................................... 10
          Venture Financing......................................................................................................................................................................... 10
             Selexys Pharma Raises $23 Million In Series A Financing ....................................................................................................... 10
             Selexys Pharma Secures Additional $2.2 Million In Venture Financing .................................................................................... 11
             Selexys Pharma Secures $3.5 Million In Seed Financing ......................................................................................................... 12
          Partnerships.................................................................................................................................................................................. 13
             Cytovance Biologics Enters Into Co-Development Agreement With Selexys Pharma .............................................................. 13
          Acquisition .................................................................................................................................................................................... 14
             Novartis Pharma To Acquire Selexys Pharma For Up To $665 Million ..................................................................................... 14
       Selexys Pharmaceuticals Corporation - Key Competitors ................................................................................................................ 16
       Key Employees ................................................................................................................................................................................ 17
       Locations And Subsidiaries .............................................................................................................................................................. 18
          Head Office ................................................................................................................................................................................... 18
       Appendix .......................................................................................................................................................................................... 19
          Methodology ................................................................................................................................................................................. 19
          About GlobalData ......................................................................................................................................................................... 19
          Contact Us .................................................................................................................................................................................... 19
          Disclaimer ..................................................................................................................................................................................... 19




Selexys Pharmaceuticals Corporation - Pharmaceuticals &                                                                                                          Reference Code: GDPH1376
				
DOCUMENT INFO
Description: Selexys Pharmaceuticals Corporation (Selexys Pharmaceuticals) is a biotechnology company, based in the US. It develops drugs for the treatment of inflammatory and thrombotic diseases. The company aims at binding two proteins, P-selectin and PSGL-1 for the treatment of acute and chronic inflammatory and thrombotic disorders. Selexys Pharmaceuticals’ product pipeline includes Anti-P-selectin, which blocks selectin function and prevents white blood cells from initiating inflammation and Anti-PSGL-1, a monoclonal antibodies targeted at inflammatory bowel diseases. Its Research and Development (R&D) activities are directed towards the preclinical development of antibody-based therapeutics for treating inflammation. Selexys Pharmaceuticals is headquartered in Oklahoma City, Oklahoma, the US.
BUY THIS DOCUMENT NOW PRICE: $250 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.